Difference between revisions of "Template:CaveQT"

From Psychiatrienet
Jump to: navigation, search
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
* During this switch ECG monitoring is advisable especially in patients prone to QT-conduction problems.
+
* During this switch you could monitor ECG, especially in patients prone to QT-conduction problems.
* There is a possibilty of QT interval prolongation.<ref> Stöllberger C, Huber JO, Finsterer J, [http://www.ncbi.nlm.nih.gov/pubmed/16096514?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum Antipsychotic drugs and QT prolongation]. Int Clin Psychopharmacol. 2005 Sep;20(5):243-51.</ref> --[[User:Walter|Walter]] 12:02, 24 August 2009 (CEST)
+
* There is a possibility of QT interval prolongation.<ref> Stöllberger C, Huber JO, Finsterer J, {{pubmed|16096514|Antipsychotic drugs and QT prolongation.}} Int Clin Psychopharmacol. 2005 Sep;20(5):243-51.</ref>
 +
<noinclude>
 +
<references />
 +
[[Category:References]]
 +
</noinclude>

Latest revision as of 15:38, 20 April 2010

  • During this switch you could monitor ECG, especially in patients prone to QT-conduction problems.
  • There is a possibility of QT interval prolongation.[1]
  1. Stöllberger C, Huber JO, Finsterer J, Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005 Sep;20(5):243-51.